Patent: 8,883,862
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
Summary for Patent: 8,883,862
Title: | Method for controlled release of parathyroid hormone from cross-linked hyaluronic acid hydrogel |
Abstract: | A method for locally controlled release of an effective amount of PTH(1-34) by a hyaluronic acid based hydrogel that can injected intra-articularly for the treatment of osteoarthritis is provided. |
Inventor(s): | Ho; Mei-Ling (Kaohsiung, TW), Eswaramoorthy; Rajalakshmanan (Kaohsiung, TW), Wu; Shun-Cheng (Kaohsiung, TW), Wang; Gwo-Jaw (Taipei, TW), Chang; Je-Ken (Kaohsiung, TW), Fu; Yin-Chih (Kaohsiung, TW), Tzeng; Cherng-Chyi (Kaohsiung, TW), Chen; Hui-Ting (Kaohsiung, TW), Wang; Yao-Hsien (Kaohsiung, TW) |
Assignee: | Kaohsiung Medical University (Kaohsiung, TW) |
Application Number: | 13/349,533 |
Patent Claims: | see list of patent claims |
Details for Patent 8,883,862
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Sign Up | 2039-03-29 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |